| Dr Philip Shin, MD | |
|
25825 Vermont Ave, Anesthesiology, Harbor City, CA 90710-3518 | |
| (310) 517-2698 | |
| Not Available |
| Full Name | Dr Philip Shin |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 22 Years |
| Location | 25825 Vermont Ave, Harbor City, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922270560 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | A97485 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - South Bay | Harbor city, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
AutoGenomics, a leader in providing automated, molecular microarray testing solutions, announced today that they have received their first Health Canada Medical Device Class III approvals for their automated INFINITI Pharmacogenomic (PGx) testing system.
Grupo Casa Saba, S.A.B. de C.V., and various Chilean legal entities that are controlled by Mr. José Codner Chijner, who is the final controller of Farmacias Ahumada S.A. announced that they have reached a definitive agreement under which GCS will acquire the control of FASA in a transaction valued at approximately US$637 million, including the assumption of US$162 million in estimated net debt as of March 31, 2010.
A University of Illinois scientist studying how membranes wrinkle has discovered a novel system for on-demand drug delivery.
Coventry Health Care, Inc. today reported consolidated operating results for the quarter ended December 31, 2009. Operating revenues totaled $3.4 billion for the quarter with net earnings of $109.1 million, or $0.74 earnings per diluted share (EPS). For the year ended December 31, 2009, total revenues from continuing operations were $13.9 billion with net earnings from continuing operations of $315.3 million, or $2.14 per diluted share.
Furthermore, a study conducted by the University of Arizona's School of Pharmacy finds that 40% of patients who receive outpatient drug therapy will experience a treatment failure or new medical problem as a result of improper use.
› Verified 4 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
AutoGenomics, a leader in providing automated, molecular microarray testing solutions, announced today that they have received their first Health Canada Medical Device Class III approvals for their automated INFINITI Pharmacogenomic (PGx) testing system.
Grupo Casa Saba, S.A.B. de C.V., and various Chilean legal entities that are controlled by Mr. José Codner Chijner, who is the final controller of Farmacias Ahumada S.A. announced that they have reached a definitive agreement under which GCS will acquire the control of FASA in a transaction valued at approximately US$637 million, including the assumption of US$162 million in estimated net debt as of March 31, 2010.
A University of Illinois scientist studying how membranes wrinkle has discovered a novel system for on-demand drug delivery.
Coventry Health Care, Inc. today reported consolidated operating results for the quarter ended December 31, 2009. Operating revenues totaled $3.4 billion for the quarter with net earnings of $109.1 million, or $0.74 earnings per diluted share (EPS). For the year ended December 31, 2009, total revenues from continuing operations were $13.9 billion with net earnings from continuing operations of $315.3 million, or $2.14 per diluted share.
Furthermore, a study conducted by the University of Arizona's School of Pharmacy finds that 40% of patients who receive outpatient drug therapy will experience a treatment failure or new medical problem as a result of improper use.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Philip Shin, MD 25825 Vermont Ave, Anesthesiology, Harbor City, CA 90710-3518 Ph: (310) 517-2698 | Dr Philip Shin, MD 25825 Vermont Ave, Anesthesiology, Harbor City, CA 90710-3518 Ph: (310) 517-2698 |
News Archive
AutoGenomics, a leader in providing automated, molecular microarray testing solutions, announced today that they have received their first Health Canada Medical Device Class III approvals for their automated INFINITI Pharmacogenomic (PGx) testing system.
Grupo Casa Saba, S.A.B. de C.V., and various Chilean legal entities that are controlled by Mr. José Codner Chijner, who is the final controller of Farmacias Ahumada S.A. announced that they have reached a definitive agreement under which GCS will acquire the control of FASA in a transaction valued at approximately US$637 million, including the assumption of US$162 million in estimated net debt as of March 31, 2010.
A University of Illinois scientist studying how membranes wrinkle has discovered a novel system for on-demand drug delivery.
Coventry Health Care, Inc. today reported consolidated operating results for the quarter ended December 31, 2009. Operating revenues totaled $3.4 billion for the quarter with net earnings of $109.1 million, or $0.74 earnings per diluted share (EPS). For the year ended December 31, 2009, total revenues from continuing operations were $13.9 billion with net earnings from continuing operations of $315.3 million, or $2.14 per diluted share.
Furthermore, a study conducted by the University of Arizona's School of Pharmacy finds that 40% of patients who receive outpatient drug therapy will experience a treatment failure or new medical problem as a result of improper use.
› Verified 4 days ago
Alexander K. Chin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
David B. Lim, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Rita Puri, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Daniel Myonghan Choi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 800-780-1230 | |
Edward J.m. Mirikitani, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Michael G. Ward, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Nghiem H. Truong, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 |